AFP and hepatocellular carcinoma: In our study group, 6 out of 38 HCC patients were AFP-negative (<13 ng/mL) and 12 out of 37 were PIVKA-II-negative (<39 mAU/mL) (cut-off values were chosen according to clinical criteria used at Kagawa University Hospital).